Your browser doesn't support javascript.
loading
Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities.
Chowdhury, Fuad; Wang, Lei; Al-Raqad, Mohammed; Amor, David J; Baxová, Alice; Bendová, Sárka; Biamino, Elisa; Brusco, Alfredo; Caluseriu, Oana; Cox, Nancy J; Froukh, Tawfiq; Gunay-Aygun, Meral; Hancárová, Miroslava; Haynes, Devon; Heide, Solveig; Hoganson, George; Kaname, Tadashi; Keren, Boris; Kosaki, Kenjiro; Kubota, Kazuo; Lemons, Jennifer M; Magriña, Maria A; Mark, Paul R; McDonald, Marie T; Montgomery, Sarah; Morley, Gina M; Ohnishi, Hidenori; Okamoto, Nobuhiko; Rodriguez-Buritica, David; Rump, Patrick; Sedlácek, Zdenek; Schatz, Krista; Streff, Haley; Uehara, Tomoko; Walia, Jagdeep S; Wheeler, Patricia G; Wiesener, Antje; Zweier, Christiane; Kawakami, Koichi; Wentzensen, Ingrid M; Lalani, Seema R; Siu, Victoria M; Bi, Weimin; Balci, Tugce B.
Afiliación
  • Chowdhury F; Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Wang L; Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, ON, Canada.
  • Al-Raqad M; Baylor Genetics Laboratory, Houston, TX, USA.
  • Amor DJ; Al-Balqa Applied University, Faculty of Medicine, Al-Salt, Jordan.
  • Baxová A; Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia.
  • Bendová S; Department of Biology and Medical Genetics, 1st Faculty of Medicine and University Hospital, Charles University, Prague, Czech Republic.
  • Biamino E; Department of Biology and Medical Genetics, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.
  • Brusco A; Department of Pediatrics, Regina Margherita Children Hospital, Turin, Italy.
  • Caluseriu O; Department of Medical Sciences, University of Torino, Torino, Italy.
  • Cox NJ; Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada.
  • Froukh T; Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.
  • Gunay-Aygun M; Department of Biotechnology and Genetic Engineering, Philadelphia University, Amman, Jordan.
  • Hancárová M; Department of Genetic Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Haynes D; Department of Biology and Medical Genetics, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.
  • Heide S; Division of Genetics, Arnold Palmer Hospital for Children-Orlando Health, Orlando, FL, USA.
  • Hoganson G; Département de Génétique and CRMR « Déficience Intellectuelle ¼, Hôpital de la Pitié Salpêtrière, APHP Sorbonne Université, Paris, France.
  • Kaname T; Department of Medical Genetics, Mercyhealth-Javon Bea Hospital, Rockford, IL, USA.
  • Keren B; Department of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Kosaki K; Département de Génétique and CRMR « Déficience Intellectuelle ¼, Hôpital de la Pitié Salpêtrière, APHP Sorbonne Université, Paris, France.
  • Kubota K; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  • Lemons JM; Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Magriña MA; Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Mark PR; Medical Specialties Unit from City Hall São Jose dos Campos, São Paulo, Brazil.
  • McDonald MT; Division of Medical Genetics and Genomics, Spectrum Health, Grand Rapids, MI, USA.
  • Montgomery S; Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC, USA.
  • Morley GM; Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC, USA.
  • Ohnishi H; Department of Medical Genetics, Mercyhealth-Javon Bea Hospital, Rockford, IL, USA.
  • Okamoto N; Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Rodriguez-Buritica D; Department of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Rump P; Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Sedlácek Z; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Schatz K; Department of Biology and Medical Genetics, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.
  • Streff H; Department of Genetic Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Uehara T; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Walia JS; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  • Wheeler PG; Department of Pediatrics, Division of Medical Genetics, Kingston General Hospital, Kingston, ON, Canada.
  • Wiesener A; Division of Genetics, Arnold Palmer Hospital for Children-Orlando Health, Orlando, FL, USA.
  • Zweier C; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Kawakami K; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Wentzensen IM; Laboratory of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Japan.
  • Lalani SR; GeneDx, Gaithersburg, MD, USA.
  • Siu VM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Bi W; Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Balci TB; Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, ON, Canada.
Genet Med ; 23(7): 1234-1245, 2021 07.
Article en En | MEDLINE | ID: mdl-33824499
PURPOSE: Proline Rich 12 (PRR12) is a gene of unknown function with suspected DNA-binding activity, expressed in developing mice and human brains. Predicted loss-of-function variants in this gene are extremely rare, indicating high intolerance of haploinsufficiency. METHODS: Three individuals with intellectual disability and iris anomalies and truncating de novo PRR12 variants were described previously. We add 21 individuals with similar PRR12 variants identified via matchmaking platforms, bringing the total number to 24. RESULTS: We observed 12 frameshift, 6 nonsense, 1 splice-site, and 2 missense variants and one patient with a gross deletion involving PRR12. Three individuals had additional genetic findings, possibly confounding the phenotype. All patients had developmental impairment. Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities. Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%). PrediXcan analysis showed that phecodes most strongly associated with reduced predicted PRR12 expression were enriched for eye- (7/30) and kidney- (4/30) phenotypes, such as wet macular degeneration and chronic kidney disease. CONCLUSION: These findings support PRR12 haploinsufficiency as a cause for a novel disorder with a wide clinical spectrum marked chiefly by neurodevelopmental and eye abnormalities.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Haploinsuficiencia / Discapacidad Intelectual Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Haploinsuficiencia / Discapacidad Intelectual Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Canadá